News

Novartis acquires full rights to IFM Tre's portfolio of NLRP3 inhibitors

Preclinical studies have shown that IFM Tre's molecules can selectively suppress inflammation caused by the NLRP3 inflammasome while allowing the rest of the immune system to continue normal operations.

Read More

Apr 02, 2019

By : Team ABLE

Israel's Ocular discovery partners with all India Institute of Medical Sciences

Ocular Discovery and AIIMSsigned a novel research partnership investigating the mechanism of action of Dipyridamole, for optimized delivery and therapeutic treatment of various Ocular Surface Disorders.

Read More

Apr 02, 2019

By : Team ABLE

Lupin appoints Christine Mundkur as an Independent Director

Pharma major Lupin Limited (Lupin) announced today the appointment of Ms. Christine Mundkur as an Independent Director with immediate effect.

Read More

Apr 02, 2019

By : Team ABLE

AstraZeneca spearheads development of a new International Life Science Innovation Park in China

The International Life Science Innovation Park will be built by the Wuxi municipal government and Wuxi High-tech District and supported by AstraZeneca as a founding partner

Read More

Mar 29, 2019

By : Team ABLE

ICMR inks MOU with African Union to promote Health Sciences Research

As per the agreement, an India-Africa health sciences collaborative platform will be established to boost different deliverables of healthcare

Read More

Mar 29, 2019

By : Team ABLE

 

BioEconomy Conclave 2026

24th February | TAJ MG Road, Bengaluru

Exhibit in the 'India Pavilion' at BIO 2026

June 22-25 | San Diego, USA

Focus Areas

Highlights